Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Javier David Benitez Fuentes"'
Autor:
Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu, Saara Mohammed, Riyaz Shah, Javier David Benitez Fuentes, Samantha Cox, Federico Monaca, Emilio Bria, María Rosario García-Campelo, Benjamin Crook, Toby Talbot, Rita Leporati, Kirsty Balachandran, Tom Newsom-Davis, Sarah Hughes, Laura Cove-Smith, Paul Taylor, Fiona Blackhall, Raffaele Califano
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background and objectives: Second-line treatment for small-cell lung cancer (SCLC) is primarily guided by the time elapsed since the last platinum dose. Rechallenge with carboplatin and etoposide has demonstrated superior outcomes compared to topotec
Externí odkaz:
https://doaj.org/article/b761da8d4bca4511a117872a9490eebc
Autor:
Salvador Gamez Casado, Javier David Benitez Fuentes, Beatriz Álvarez Rodríguez, Gema García Ledo
Publikováno v:
Respirology Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract Oncogene‐negative, PDL1‐negative metastatic non‐small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance to conventional therapies. The case report presented addresses a 55‐year‐
Externí odkaz:
https://doaj.org/article/39eeebcce12a4a34ba1b236acf2cafde
Autor:
Javier David Benitez Fuentes, Kauzar Mohamed Mohamed, Alicia de Luna Aguilar, Carlos Jiménez García, Kissy Guevara-Hoyer, Miguel Fernandez-Arquero, M Antonia Rodríguez de la Peña, Laura Garciía Bravo, Alejandro Francisco Jiménez Ortega, Paloma Flores Navarro, Jorge Bartolome Arcilla, Bárbara Alonso Arenilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, María Montealegre Sanz, Silvia Sanchez-Ramon, Pedro Perez Segura
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionEvidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in cancer patients after repeated booster doses. The possibility of T-cell
Externí odkaz:
https://doaj.org/article/205ced2c0cb34c1fa28fb27310f18bf2
Autor:
Ignacio Martinez Capella, Sara Gil Useros, Macarena Torrego Ellacuría, Laura Llorente Sanz, Jorge Bartolomé Arcilla, Paloma Flores Navarro, Alicia de Luna Aguilar, Alberto Delgado-Iribarren García-Campero, Javier David Benitez Fuentes, Elvira Baos Muñoz, Alejandro Francisco Jimenez Ortega, Pedro Pérez Segura
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer patients were not included or were underrepresented. Methods: The objective of this study is to
Externí odkaz:
https://doaj.org/article/106d3de9f04449fea57a5cfd285bf249
Autor:
Alfonso Lopez de Sa Lorenzo, Paloma Flores Navarro, Berta Laguna Fonseca, Carmen Toledano Rojas, Alicia de Luna Aguilar, Javier David Benitez Fuentes, Tania Rocha Iñigo, Clara Frick, Richa Shah, Natalia Vidal Cassinello, Alejandro Francisco Jimenez Ortega
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Human bocavirus (HBoV) is a viral pathogen from the genus Bocaparvovirus (family Parvoviridae, subfamily Parvovirinae) discovered in 2005. Most of available literature is about HBoV in children and adults with hematological malignancies a
Externí odkaz:
https://doaj.org/article/5519d9ff57dc4c31830f8a89d7cd6279
Autor:
Jorge Bartolome, Consolacion Molto, Javier David Benitez-Fuentes, Gonzalo Fernandez-Hinojal, Aranzazu Manzano, Pedro Perez-Segura, Abhenil Mittal, Faris Tamimi, Eitan Amir, Alberto Ocana
Publikováno v:
Frontiers in Immunology. 14
IntroductionIdentification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a key goal in cancer research. An example is the human leukocyte antigen G (HLA-G), a nonclassical ma
Autor:
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Alberto Delgado-Iribarren Garcia-Campero, Elvira Baos Muñoz, Sara Gil Useros, Pedro Perez Segura
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-047
Autor:
Alicia de Luna Aguilar, Javier David Benitez Fuentes, Jorge Bartolome Arcilla, Richa Shah, Manushak Avagyan, Clara Frick, Alfonso Lopez de Sa Lorenzo, Carmen Toledano Rojas, Fernando Moreno Anton, Jose Angel Garcia Saenz
Background: Breast cancer is the most common cancer among women worldwide. Most breast cancers are estrogen receptor-positive and epidermal growth factor receptor 2 negative (ER+/HER2-). A small proportion of these cases are metastatic, and cyclin-de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8dbb4efee82ff63b6120a199bd62246
https://doi.org/10.21203/rs.3.rs-1796416/v3
https://doi.org/10.21203/rs.3.rs-1796416/v3
Autor:
Javier David Benitez Fuentes, Alfonso Lopez de Sa Lorenzo, Alberto Elpidio Calvo Elias, Carmen Toledano Rojas, Monica Granja Ortega
Publikováno v:
Cureus.
Autor:
Alicia de Luna Aguilar, Javier David Benitez Fuentes, Jorge Bartolome Arcilla, Richa Shah, Manushak Avagyan, Clara Frick, Alfonso Lopez de Sa Lorenzo, Carmen Toledano Rojas, Fernando Moreno Anton, Jose Angel Garcia Saenz
Background Breast cancer is the most frequent cancer in women worldwide. Most breast cancer cases are estrogen receptor positive and epidermal growth factor receptor 2 negative (ER+/HER2-). A small proportion of these cases are metastatic with Cyclin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74740875073b381e93db62d48403d65
https://doi.org/10.21203/rs.3.rs-1796416/v1
https://doi.org/10.21203/rs.3.rs-1796416/v1